Newly developed drugs go through stringent means of drug effect testing where only if the
new drug proved to be better than the one presently in the market is passed. If the new
drug fails this test, then it will be stopped from further being used. The drugs are tested
through a series of clinical trials. There are 4 stages of clinical trials in most of the
countries including Europe. In these trails the new potential drugs side effects are noted,
its effect on healthy individuals is noted and finally its efficacy against the disease or
disorder it is meant to cure is noted. Not only that, it is also pitched against a
completely fake drug known as a placebo which the patients do not have any knowledge about.
This way the patient can not fake that he is cured so that the company can pay him. Only
after it gets through all these tests will it be allowed to sell in the market. But lately
the increasing practice of outsourcing drug trails to cheap destinations such as south
America, Bangladesh and other countries has given rise to corruption is drug trails. The
cheap drug trail outsourcing destinations support their results on the generosity of the
clients. This makes it harder to distinguish between a potentially beneficial drug and a
fake drug. The doctors who go through the files, tend to believe that the drug showing high
curing rates on paper will be effective against his patients and offer it to them. Recently
the FDA found some irregularities with a psychoactive drug that was produced in the
university of Minnesota. This drug was extremely dangerous but was anyways given as green
signal for use in the market without fair and proper clinical trails. This is going to make
the process of clearing drugs further difficult with drug companies outsourcing
manufacturing to developing nations.
